Almirall’s new AI deal with Absci; Jazz partners with Autifony; SAB raises $67M
Plus, Vittoria raises $15 million, and a spinout from Glasgow and Oxford universities gets £4.3 million in seed funding:
Almirall, Absci partner on AI drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
